Regenxbio RGNX
NASDAQ RGNX
$7.40 +0.25 (+3.50%)
At close: Oct 20, 2026 · 4:00 PM EDT

Regenxbio (RGNX) EPS (Basic) (2014 - 2026)

Updated

Regenxbio's EPS (Basic) came in at $0.43 for Q2 2026, compared with -$1.38 a year earlier.

Analysis

Regenxbio (RGNX) EPS (Basic) (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regenxbio reported EPS (Basic) of -$3.36; for FY2025, it was -$3.76.

  • Going back by year, EPS (Basic) was -$4.59 in FY2024, -$6.02 in FY2023, -$6.50 in FY2022 and $3.01 in FY2021.
  • The Q2 2026 figure represents the highest quarterly EPS (Basic) since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.95
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.30
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.68
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.62
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.40
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Regenxbio 391.13 Mn -541.96 Mn - 0.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.43
Dec 31, 2025 -1.30
Sep 30, 2025 -1.20
Jun 30, 2025 -1.38
Mar 31, 2025 0.12
Dec 31, 2024 -1.03
Sep 30, 2024 -1.17
Jun 30, 2024 -1.05
Mar 31, 2024 -1.38
Dec 31, 2023 -1.44
Sep 30, 2023 -1.41
Jun 30, 2023 -1.66
Mar 31, 2023 -1.53
Dec 31, 2022 -1.39
Sep 30, 2022 -1.75
Jun 30, 2022 -1.58
Mar 31, 2022 -1.79
Dec 31, 2021 6.93
Sep 30, 2021 -1.37
Jun 30, 2021 -1.36
API Access

Regenxbio EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=RGNX&period=max&api_key=YOUR_API_KEY